Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
CA 2381882 C · Owner: Ledeboer, Mark · Inventors: Ledeboer, Mark; Bemis, Guy; Gao, Huai
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides compounds of formula (I) where R1 is H CONH2, T(n)-R, or T(n)-Ar2, n may be zero or one and G, XYZ, and Q are as described , below. These compounds are inhibitors of protein kinase particularly , inhibitors of JNK, a mammalian protein kinase involved cell proliferation cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 11, 2000 and granted January 25, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 11, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 11, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.